FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
PrecisionCHD is the First Integrated Epigenetic-Genetic-Based Blood Test for the Early Detection of Coronary Heart Disease
CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart... More

